Quantbot Technologies LP Vaxcyte, Inc. Transaction History

Quantbot Technologies LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 06, 2024	BUY	$59.79 - $81.05 $3,408 - $4,619	57 New	57 $3,000
Q4 2022 Feb 13, 2023	BUY	$20.58 - $47.95 $454,817 - $1.06 Million	22,100 New	22,100 $1.06 Million
Q1 2022 May 16, 2022	SELL	$17.46 - $26.36 $31,428 - $47,448	-1,800 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$19.32 - $26.45 $28,980 - $39,675	-1,500 Reduced 45.45%	1,800 $42,000
Q3 2021 Nov 09, 2021	BUY	$20.26 - $26.97 $36,468 - $48,546	1,800 Added 120.0%	3,300 $83,000
Q2 2021 Aug 12, 2021	BUY	$16.45 - $24.06 $24,675 - $36,090	1,500 New	1,500 $33,000

352

122M

775K

433K

Ticker PCVX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,315,100
Market Cap $5.1B
Description
Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine that is in Phase 1/2 clinical trials to treat invasive pneumococcal disease and pneumonia. The company a...

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

Stay updated on Quantbot Technologies LP with notifications on news.